These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35746892)

  • 21. LB100 ameliorates nonalcoholic fatty liver disease
    Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
    World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatoprotective Effect of Seed Coat ofEuryale ferox Extract in Non-alcoholic Fatty Liver Disease Induced by High-fat Diet in Mice by Increasing IRs-1 and Inhibiting CYP2E1.
    Jian T; Yu C; Ding X; Chen J; Li J; Zuo Y; Ren B; Lv H; Li W
    J Oleo Sci; 2019 Jun; 68(6):581-589. PubMed ID: 31092797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-fat diet-induced renal cell apoptosis and oxidative stress in spontaneously hypertensive rat are ameliorated by fenofibrate through the PPARα-FoxO3a-PGC-1α pathway.
    Chung HW; Lim JH; Kim MY; Shin SJ; Chung S; Choi BS; Kim HW; Kim YS; Park CW; Chang YS
    Nephrol Dial Transplant; 2012 Jun; 27(6):2213-25. PubMed ID: 22076434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amelioration of diet-induced steatohepatitis in mice following combined therapy with ASO-Fsp27 and fenofibrate.
    Rajamoorthi A; Arias N; Basta J; Lee RG; Baldán Á
    J Lipid Res; 2017 Nov; 58(11):2127-2138. PubMed ID: 28874443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fenofibrate Regulates Visceral Obesity and Nonalcoholic Steatohepatitis in Obese Female Ovariectomized C57BL/6J Mice.
    Shin Y; Lee M; Lee D; Jang J; Shin SS; Yoon M
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual PPARα/γ agonist saroglitazar improves liver histopathology and biochemistry in experimental NASH models.
    Jain MR; Giri SR; Bhoi B; Trivedi C; Rath A; Rathod R; Ranvir R; Kadam S; Patel H; Swain P; Roy SS; Das N; Karmakar E; Wahli W; Patel PR
    Liver Int; 2018 Jun; 38(6):1084-1094. PubMed ID: 29164820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delayed treatment with fenofibrate protects against high-fat diet-induced kidney injury in mice: the possible role of AMPK autophagy.
    Sohn M; Kim K; Uddin MJ; Lee G; Hwang I; Kang H; Kim H; Lee JH; Ha H
    Am J Physiol Renal Physiol; 2017 Feb; 312(2):F323-F334. PubMed ID: 27465995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peroxisome proliferator-activated receptor-alpha activation and dipeptidyl peptidase-4 inhibition target dysbiosis to treat fatty liver in obese mice.
    Silva-Veiga FM; Miranda CS; Vasques-Monteiro IML; Souza-Tavares H; Martins FF; Daleprane JB; Souza-Mello V
    World J Gastroenterol; 2022 May; 28(17):1814-1829. PubMed ID: 35633911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chaperonin counteracts diet-induced non-alcoholic fatty liver disease by aiding sirtuin 3 in the control of fatty acid oxidation.
    Weng SW; Wu JC; Shen FC; Chang YH; Su YJ; Lian WS; Tai MH; Su CH; Chuang JH; Lin TK; Liou CW; Chu TH; Kao YH; Wang FS; Wang PW
    Diabetologia; 2023 May; 66(5):913-930. PubMed ID: 36692509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of peroxisomal lipid metabolism in mice fed a high-fat diet.
    Kozawa S; Honda A; Kajiwara N; Takemoto Y; Nagase T; Nikami H; Okano Y; Nakashima S; Shimozawa N
    Mol Med Rep; 2011; 4(6):1157-62. PubMed ID: 21850377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. α-Lactalbumin Peptide Asp-Gln-Trp Ameliorates Hepatic Steatosis and Oxidative Stress in Free Fatty Acids-Treated HepG2 Cells and High-Fat Diet-Induced NAFLD Mice by Activating the PPARα Pathway.
    Chen H; Ma Y; Qi X; Tian J; Ma Y; Niu T
    Mol Nutr Food Res; 2023 Aug; 67(16):e2200499. PubMed ID: 37354055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mice with a deficiency in Peroxisomal Membrane Protein 4 (PXMP4) display mild changes in hepatic lipid metabolism.
    Blankestijn M; Bloks VW; Struik D; Huijkman N; Kloosterhuis N; Wolters JC; Wanders RJA; Vaz FM; Islinger M; Kuipers F; van de Sluis B; Groen AK; Verkade HJ; Jonker JW
    Sci Rep; 2022 Feb; 12(1):2512. PubMed ID: 35169201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Singular effects of PPAR agonists on nonalcoholic fatty liver disease of diet-induced obese mice.
    Barbosa-da-Silva S; Souza-Mello V; Magliano DC; Marinho Tde S; Aguila MB; Mandarim-de-Lacerda CA
    Life Sci; 2015 Apr; 127():73-81. PubMed ID: 25748419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The hepatoprotective effects of n3-polyunsaturated fatty acids against non-alcoholic fatty liver disease in diabetic rats through the FOXO1/PPARα/GABARAPL1 signalling pathway.
    Ramadan NM; Elmasry K; Elsayed HRH; El-Mesery A; Eraky SM
    Life Sci; 2022 Dec; 311(Pt A):121145. PubMed ID: 36336129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired Peroxisomal Fitness in Obese Mice, a Vicious Cycle Exacerbating Adipocyte Dysfunction
    Piao L; Dorotea D; Jiang S; Koh EH; Oh GT; Ha H
    Antioxid Redox Signal; 2019 Dec; 31(18):1339-1351. PubMed ID: 31530170
    [No Abstract]   [Full Text] [Related]  

  • 36. Profound Modification of Fatty Acid Profile and Endocannabinoid-Related Mediators in PPARα Agonist Fenofibrate-Treated Mice.
    Murru E; Muntoni AL; Manca C; Aroni S; Pistis M; Banni S; Carta G
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preventive Effect of Citrus aurantium Peel Extract on High-Fat Diet-Induced Non-alcoholic Fatty Liver in Mice.
    Han HY; Lee SK; Choi BK; Lee DR; Lee HJ; Kim TW
    Biol Pharm Bull; 2019; 42(2):255-260. PubMed ID: 30713255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peroxisome proliferator-activated receptor-alpha gene level differently affects lipid metabolism and inflammation in apolipoprotein E2 knock-in mice.
    Lalloyer F; Wouters K; Baron M; Caron S; Vallez E; Vanhoutte J; Baugé E; Shiri-Sverdlov R; Hofker M; Staels B; Tailleux A
    Arterioscler Thromb Vasc Biol; 2011 Jul; 31(7):1573-9. PubMed ID: 21474829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential involvement of PPAR α activation in diminishing the hepatoprotective effect of fenofibrate in NAFLD: Accuracy of non- invasive panel in determining the stage of liver fibrosis in rats.
    Hamed AM; El-Kharashi OA; Boctor SS; Abd-Elaziz LF
    Biomed Pharmacother; 2017 Jan; 85():68-78. PubMed ID: 27930988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective peroxisome proliferator-activated receptor-α modulator K-877 efficiently activates the peroxisome proliferator-activated receptor-α pathway and improves lipid metabolism in mice.
    Takei K; Han SI; Murayama Y; Satoh A; Oikawa F; Ohno H; Osaki Y; Matsuzaka T; Sekiya M; Iwasaki H; Yatoh S; Yahagi N; Suzuki H; Yamada N; Nakagawa Y; Shimano H
    J Diabetes Investig; 2017 Jul; 8(4):446-452. PubMed ID: 28084058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.